nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CA1—esophageal cancer	0.401	0.569	CbGaD
Topiramate—CA2—esophageal cancer	0.304	0.431	CbGaD
Topiramate—CA6—exocrine gland—esophageal cancer	0.00279	0.135	CbGeAlD
Topiramate—GRIK3—lymph node—esophageal cancer	0.00112	0.0541	CbGeAlD
Topiramate—GRIK5—lymph node—esophageal cancer	0.00112	0.0541	CbGeAlD
Topiramate—CA7—trachea—esophageal cancer	0.00111	0.0536	CbGeAlD
Topiramate—CA2—exocrine gland—esophageal cancer	0.000961	0.0465	CbGeAlD
Topiramate—CA7—digestive system—esophageal cancer	0.000954	0.0462	CbGeAlD
Topiramate—CA9—digestive system—esophageal cancer	0.000838	0.0405	CbGeAlD
Topiramate—GRIA1—lung—esophageal cancer	0.000772	0.0373	CbGeAlD
Topiramate—CA4—neck—esophageal cancer	0.000741	0.0359	CbGeAlD
Topiramate—CA12—trachea—esophageal cancer	0.00072	0.0349	CbGeAlD
Topiramate—CA12—digestive system—esophageal cancer	0.00062	0.03	CbGeAlD
Topiramate—CA2—neck—esophageal cancer	0.000615	0.0297	CbGeAlD
Topiramate—SCN1A—lung—esophageal cancer	0.000559	0.0271	CbGeAlD
Topiramate—SCN5A—digestive system—esophageal cancer	0.000539	0.0261	CbGeAlD
Topiramate—CA12—lung—esophageal cancer	0.000518	0.025	CbGeAlD
Topiramate—CA1—digestive system—esophageal cancer	0.000491	0.0238	CbGeAlD
Topiramate—CA5B—lung—esophageal cancer	0.000464	0.0225	CbGeAlD
Topiramate—CA4—trachea—esophageal cancer	0.000446	0.0216	CbGeAlD
Topiramate—GABRB2—lung—esophageal cancer	0.000436	0.0211	CbGeAlD
Topiramate—CA2—epithelium—esophageal cancer	0.000418	0.0202	CbGeAlD
Topiramate—CA2—bronchus—esophageal cancer	0.000412	0.0199	CbGeAlD
Topiramate—CA1—lung—esophageal cancer	0.00041	0.0198	CbGeAlD
Topiramate—CA2—smooth muscle tissue—esophageal cancer	0.000403	0.0195	CbGeAlD
Topiramate—CA4—digestive system—esophageal cancer	0.000384	0.0186	CbGeAlD
Topiramate—CA2—trachea—esophageal cancer	0.00037	0.0179	CbGeAlD
Topiramate—CYP2C19—digestive system—esophageal cancer	0.000347	0.0168	CbGeAlD
Topiramate—CA4—lung—esophageal cancer	0.00032	0.0155	CbGeAlD
Topiramate—CA2—digestive system—esophageal cancer	0.000318	0.0154	CbGeAlD
Topiramate—CA5B—lymph node—esophageal cancer	0.000318	0.0154	CbGeAlD
Topiramate—CA1—lymph node—esophageal cancer	0.00028	0.0136	CbGeAlD
Topiramate—CA2—lung—esophageal cancer	0.000266	0.0129	CbGeAlD
Topiramate—CA4—lymph node—esophageal cancer	0.000219	0.0106	CbGeAlD
Topiramate—Polyuria—Methotrexate—esophageal cancer	0.000207	0.00157	CcSEcCtD
Topiramate—Immune system disorder—Cisplatin—esophageal cancer	0.000207	0.00157	CcSEcCtD
Topiramate—Mediastinal disorder—Cisplatin—esophageal cancer	0.000206	0.00156	CcSEcCtD
Topiramate—CYP3A4—digestive system—esophageal cancer	0.000205	0.00993	CbGeAlD
Topiramate—Angina pectoris—Capecitabine—esophageal cancer	0.000205	0.00156	CcSEcCtD
Topiramate—Sweating increased—Capecitabine—esophageal cancer	0.000205	0.00156	CcSEcCtD
Topiramate—Bronchitis—Capecitabine—esophageal cancer	0.000203	0.00154	CcSEcCtD
Topiramate—Alopecia—Cisplatin—esophageal cancer	0.000202	0.00153	CcSEcCtD
Topiramate—Abdominal discomfort—Capecitabine—esophageal cancer	0.000202	0.00153	CcSEcCtD
Topiramate—Hepatic failure—Methotrexate—esophageal cancer	0.000202	0.00153	CcSEcCtD
Topiramate—Pancytopenia—Capecitabine—esophageal cancer	0.0002	0.00152	CcSEcCtD
Topiramate—Malnutrition—Cisplatin—esophageal cancer	0.000199	0.00151	CcSEcCtD
Topiramate—Erythema—Cisplatin—esophageal cancer	0.000199	0.00151	CcSEcCtD
Topiramate—Dysuria—Capecitabine—esophageal cancer	0.000197	0.00149	CcSEcCtD
Topiramate—Neutropenia—Capecitabine—esophageal cancer	0.000197	0.00149	CcSEcCtD
Topiramate—Flatulence—Cisplatin—esophageal cancer	0.000196	0.00149	CcSEcCtD
Topiramate—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000196	0.00148	CcSEcCtD
Topiramate—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000192	0.00146	CcSEcCtD
Topiramate—Weight increased—Capecitabine—esophageal cancer	0.000192	0.00145	CcSEcCtD
Topiramate—Visual disturbance—Methotrexate—esophageal cancer	0.000191	0.00145	CcSEcCtD
Topiramate—Muscle spasms—Cisplatin—esophageal cancer	0.000191	0.00145	CcSEcCtD
Topiramate—Weight decreased—Capecitabine—esophageal cancer	0.000191	0.00144	CcSEcCtD
Topiramate—Hyperglycaemia—Capecitabine—esophageal cancer	0.00019	0.00144	CcSEcCtD
Topiramate—Pneumonia—Capecitabine—esophageal cancer	0.000189	0.00143	CcSEcCtD
Topiramate—Infestation NOS—Capecitabine—esophageal cancer	0.000188	0.00142	CcSEcCtD
Topiramate—Infestation—Capecitabine—esophageal cancer	0.000188	0.00142	CcSEcCtD
Topiramate—Vision blurred—Cisplatin—esophageal cancer	0.000188	0.00142	CcSEcCtD
Topiramate—Depression—Capecitabine—esophageal cancer	0.000187	0.00142	CcSEcCtD
Topiramate—Tremor—Cisplatin—esophageal cancer	0.000187	0.00141	CcSEcCtD
Topiramate—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000186	0.00141	CcSEcCtD
Topiramate—Lethargy—Methotrexate—esophageal cancer	0.000185	0.0014	CcSEcCtD
Topiramate—Ill-defined disorder—Cisplatin—esophageal cancer	0.000185	0.0014	CcSEcCtD
Topiramate—Renal failure—Capecitabine—esophageal cancer	0.000185	0.0014	CcSEcCtD
Topiramate—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000184	0.0014	CcSEcCtD
Topiramate—Anaemia—Cisplatin—esophageal cancer	0.000184	0.0014	CcSEcCtD
Topiramate—Stomatitis—Capecitabine—esophageal cancer	0.000183	0.00139	CcSEcCtD
Topiramate—Urinary tract infection—Capecitabine—esophageal cancer	0.000183	0.00138	CcSEcCtD
Topiramate—Conjunctivitis—Capecitabine—esophageal cancer	0.000183	0.00138	CcSEcCtD
Topiramate—CA2—lymph node—esophageal cancer	0.000182	0.00879	CbGeAlD
Topiramate—Osteoarthritis—Methotrexate—esophageal cancer	0.000181	0.00138	CcSEcCtD
Topiramate—Malaise—Cisplatin—esophageal cancer	0.00018	0.00136	CcSEcCtD
Topiramate—Haematuria—Capecitabine—esophageal cancer	0.000179	0.00136	CcSEcCtD
Topiramate—Leukopenia—Cisplatin—esophageal cancer	0.000178	0.00135	CcSEcCtD
Topiramate—Epistaxis—Capecitabine—esophageal cancer	0.000177	0.00134	CcSEcCtD
Topiramate—Agranulocytosis—Capecitabine—esophageal cancer	0.000175	0.00133	CcSEcCtD
Topiramate—Irritability—Methotrexate—esophageal cancer	0.000173	0.00131	CcSEcCtD
Topiramate—Convulsion—Cisplatin—esophageal cancer	0.000172	0.00131	CcSEcCtD
Topiramate—Mood swings—Methotrexate—esophageal cancer	0.000172	0.0013	CcSEcCtD
Topiramate—Bradycardia—Capecitabine—esophageal cancer	0.000172	0.0013	CcSEcCtD
Topiramate—Ataxia—Methotrexate—esophageal cancer	0.000171	0.00129	CcSEcCtD
Topiramate—Myalgia—Cisplatin—esophageal cancer	0.000169	0.00129	CcSEcCtD
Topiramate—Haemoglobin—Capecitabine—esophageal cancer	0.000169	0.00128	CcSEcCtD
Topiramate—Rhinitis—Capecitabine—esophageal cancer	0.000169	0.00128	CcSEcCtD
Topiramate—Anxiety—Cisplatin—esophageal cancer	0.000169	0.00128	CcSEcCtD
Topiramate—Haemorrhage—Capecitabine—esophageal cancer	0.000169	0.00128	CcSEcCtD
Topiramate—Hepatitis—Capecitabine—esophageal cancer	0.000169	0.00128	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000168	0.00128	CcSEcCtD
Topiramate—Hypoaesthesia—Capecitabine—esophageal cancer	0.000168	0.00127	CcSEcCtD
Topiramate—Liver function test abnormal—Methotrexate—esophageal cancer	0.000167	0.00127	CcSEcCtD
Topiramate—Discomfort—Cisplatin—esophageal cancer	0.000167	0.00127	CcSEcCtD
Topiramate—Pharyngitis—Capecitabine—esophageal cancer	0.000167	0.00127	CcSEcCtD
Topiramate—Urinary tract disorder—Capecitabine—esophageal cancer	0.000166	0.00126	CcSEcCtD
Topiramate—Oedema peripheral—Capecitabine—esophageal cancer	0.000166	0.00126	CcSEcCtD
Topiramate—Connective tissue disorder—Capecitabine—esophageal cancer	0.000166	0.00126	CcSEcCtD
Topiramate—Urethral disorder—Capecitabine—esophageal cancer	0.000165	0.00125	CcSEcCtD
Topiramate—Breast disorder—Methotrexate—esophageal cancer	0.000164	0.00124	CcSEcCtD
Topiramate—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000163	0.00124	CcSEcCtD
Topiramate—Oedema—Cisplatin—esophageal cancer	0.000162	0.00123	CcSEcCtD
Topiramate—Visual impairment—Capecitabine—esophageal cancer	0.000162	0.00123	CcSEcCtD
Topiramate—Infection—Cisplatin—esophageal cancer	0.000161	0.00122	CcSEcCtD
Topiramate—Erythema multiforme—Capecitabine—esophageal cancer	0.000159	0.00121	CcSEcCtD
Topiramate—Nervous system disorder—Cisplatin—esophageal cancer	0.000159	0.00121	CcSEcCtD
Topiramate—Thrombocytopenia—Cisplatin—esophageal cancer	0.000159	0.00121	CcSEcCtD
Topiramate—Tachycardia—Cisplatin—esophageal cancer	0.000159	0.0012	CcSEcCtD
Topiramate—Skin disorder—Cisplatin—esophageal cancer	0.000158	0.0012	CcSEcCtD
Topiramate—Eye disorder—Capecitabine—esophageal cancer	0.000158	0.00119	CcSEcCtD
Topiramate—Tinnitus—Capecitabine—esophageal cancer	0.000157	0.00119	CcSEcCtD
Topiramate—Hyperhidrosis—Cisplatin—esophageal cancer	0.000157	0.00119	CcSEcCtD
Topiramate—Asthma—Methotrexate—esophageal cancer	0.000157	0.00119	CcSEcCtD
Topiramate—Flushing—Capecitabine—esophageal cancer	0.000156	0.00119	CcSEcCtD
Topiramate—Cardiac disorder—Capecitabine—esophageal cancer	0.000156	0.00119	CcSEcCtD
Topiramate—Eosinophilia—Methotrexate—esophageal cancer	0.000155	0.00118	CcSEcCtD
Topiramate—Anorexia—Cisplatin—esophageal cancer	0.000155	0.00117	CcSEcCtD
Topiramate—Pancreatitis—Methotrexate—esophageal cancer	0.000154	0.00117	CcSEcCtD
Topiramate—Angiopathy—Capecitabine—esophageal cancer	0.000153	0.00116	CcSEcCtD
Topiramate—Immune system disorder—Capecitabine—esophageal cancer	0.000152	0.00115	CcSEcCtD
Topiramate—Mediastinal disorder—Capecitabine—esophageal cancer	0.000152	0.00115	CcSEcCtD
Topiramate—Hypotension—Cisplatin—esophageal cancer	0.000152	0.00115	CcSEcCtD
Topiramate—Chills—Capecitabine—esophageal cancer	0.000151	0.00115	CcSEcCtD
Topiramate—Abdominal discomfort—Methotrexate—esophageal cancer	0.00015	0.00114	CcSEcCtD
Topiramate—Alopecia—Capecitabine—esophageal cancer	0.000149	0.00113	CcSEcCtD
Topiramate—Pancytopenia—Methotrexate—esophageal cancer	0.000149	0.00113	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000148	0.00112	CcSEcCtD
Topiramate—Mental disorder—Capecitabine—esophageal cancer	0.000148	0.00112	CcSEcCtD
Topiramate—Malnutrition—Capecitabine—esophageal cancer	0.000147	0.00111	CcSEcCtD
Topiramate—Erythema—Capecitabine—esophageal cancer	0.000147	0.00111	CcSEcCtD
Topiramate—Dysuria—Methotrexate—esophageal cancer	0.000147	0.00111	CcSEcCtD
Topiramate—Neutropenia—Methotrexate—esophageal cancer	0.000147	0.00111	CcSEcCtD
Topiramate—Paraesthesia—Cisplatin—esophageal cancer	0.000146	0.00111	CcSEcCtD
Topiramate—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000146	0.0011	CcSEcCtD
Topiramate—Dyspnoea—Cisplatin—esophageal cancer	0.000145	0.0011	CcSEcCtD
Topiramate—Flatulence—Capecitabine—esophageal cancer	0.000145	0.0011	CcSEcCtD
Topiramate—Erectile dysfunction—Methotrexate—esophageal cancer	0.000144	0.00109	CcSEcCtD
Topiramate—Dysgeusia—Capecitabine—esophageal cancer	0.000144	0.00109	CcSEcCtD
Topiramate—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000143	0.00109	CcSEcCtD
Topiramate—Back pain—Capecitabine—esophageal cancer	0.000142	0.00108	CcSEcCtD
Topiramate—Decreased appetite—Cisplatin—esophageal cancer	0.000141	0.00107	CcSEcCtD
Topiramate—Muscle spasms—Capecitabine—esophageal cancer	0.000141	0.00107	CcSEcCtD
Topiramate—Pneumonia—Methotrexate—esophageal cancer	0.000141	0.00107	CcSEcCtD
Topiramate—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00014	0.00106	CcSEcCtD
Topiramate—Infestation—Methotrexate—esophageal cancer	0.00014	0.00106	CcSEcCtD
Topiramate—Infestation NOS—Methotrexate—esophageal cancer	0.00014	0.00106	CcSEcCtD
Topiramate—Depression—Methotrexate—esophageal cancer	0.000139	0.00106	CcSEcCtD
Topiramate—Pain—Cisplatin—esophageal cancer	0.000139	0.00105	CcSEcCtD
Topiramate—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000139	0.00105	CcSEcCtD
Topiramate—Vision blurred—Capecitabine—esophageal cancer	0.000138	0.00105	CcSEcCtD
Topiramate—Tremor—Capecitabine—esophageal cancer	0.000137	0.00104	CcSEcCtD
Topiramate—Renal failure—Methotrexate—esophageal cancer	0.000137	0.00104	CcSEcCtD
Topiramate—Stomatitis—Methotrexate—esophageal cancer	0.000136	0.00103	CcSEcCtD
Topiramate—Ill-defined disorder—Capecitabine—esophageal cancer	0.000136	0.00103	CcSEcCtD
Topiramate—Conjunctivitis—Methotrexate—esophageal cancer	0.000136	0.00103	CcSEcCtD
Topiramate—Anaemia—Capecitabine—esophageal cancer	0.000136	0.00103	CcSEcCtD
Topiramate—Feeling abnormal—Cisplatin—esophageal cancer	0.000134	0.00102	CcSEcCtD
Topiramate—Haematuria—Methotrexate—esophageal cancer	0.000133	0.00101	CcSEcCtD
Topiramate—Malaise—Capecitabine—esophageal cancer	0.000132	0.001	CcSEcCtD
Topiramate—Epistaxis—Methotrexate—esophageal cancer	0.000132	0.001	CcSEcCtD
Topiramate—Vertigo—Capecitabine—esophageal cancer	0.000132	0.001	CcSEcCtD
Topiramate—Syncope—Capecitabine—esophageal cancer	0.000132	0.000998	CcSEcCtD
Topiramate—Leukopenia—Capecitabine—esophageal cancer	0.000131	0.000996	CcSEcCtD
Topiramate—Agranulocytosis—Methotrexate—esophageal cancer	0.00013	0.000989	CcSEcCtD
Topiramate—Palpitations—Capecitabine—esophageal cancer	0.00013	0.000983	CcSEcCtD
Topiramate—Loss of consciousness—Capecitabine—esophageal cancer	0.000129	0.000978	CcSEcCtD
Topiramate—Body temperature increased—Cisplatin—esophageal cancer	0.000128	0.000974	CcSEcCtD
Topiramate—Cough—Capecitabine—esophageal cancer	0.000128	0.000971	CcSEcCtD
Topiramate—Hypertension—Capecitabine—esophageal cancer	0.000127	0.000961	CcSEcCtD
Topiramate—Haemoglobin—Methotrexate—esophageal cancer	0.000126	0.000956	CcSEcCtD
Topiramate—Haemorrhage—Methotrexate—esophageal cancer	0.000125	0.000952	CcSEcCtD
Topiramate—Hepatitis—Methotrexate—esophageal cancer	0.000125	0.000952	CcSEcCtD
Topiramate—Myalgia—Capecitabine—esophageal cancer	0.000125	0.000947	CcSEcCtD
Topiramate—Arthralgia—Capecitabine—esophageal cancer	0.000125	0.000947	CcSEcCtD
Topiramate—Chest pain—Capecitabine—esophageal cancer	0.000125	0.000947	CcSEcCtD
Topiramate—Pharyngitis—Methotrexate—esophageal cancer	0.000125	0.000944	CcSEcCtD
Topiramate—Anxiety—Capecitabine—esophageal cancer	0.000125	0.000944	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000124	0.000941	CcSEcCtD
Topiramate—Urinary tract disorder—Methotrexate—esophageal cancer	0.000124	0.00094	CcSEcCtD
Topiramate—Discomfort—Capecitabine—esophageal cancer	0.000123	0.000936	CcSEcCtD
Topiramate—Urethral disorder—Methotrexate—esophageal cancer	0.000123	0.000933	CcSEcCtD
Topiramate—Dry mouth—Capecitabine—esophageal cancer	0.000122	0.000927	CcSEcCtD
Topiramate—Visual impairment—Methotrexate—esophageal cancer	0.000121	0.000917	CcSEcCtD
Topiramate—Confusional state—Capecitabine—esophageal cancer	0.000121	0.000916	CcSEcCtD
Topiramate—Oedema—Capecitabine—esophageal cancer	0.00012	0.000908	CcSEcCtD
Topiramate—Hypersensitivity—Cisplatin—esophageal cancer	0.00012	0.000908	CcSEcCtD
Topiramate—Infection—Capecitabine—esophageal cancer	0.000119	0.000902	CcSEcCtD
Topiramate—Erythema multiforme—Methotrexate—esophageal cancer	0.000119	0.0009	CcSEcCtD
Topiramate—Shock—Capecitabine—esophageal cancer	0.000118	0.000894	CcSEcCtD
Topiramate—Nervous system disorder—Capecitabine—esophageal cancer	0.000117	0.000891	CcSEcCtD
Topiramate—Eye disorder—Methotrexate—esophageal cancer	0.000117	0.000889	CcSEcCtD
Topiramate—Thrombocytopenia—Capecitabine—esophageal cancer	0.000117	0.000889	CcSEcCtD
Topiramate—Tinnitus—Methotrexate—esophageal cancer	0.000117	0.000887	CcSEcCtD
Topiramate—Tachycardia—Capecitabine—esophageal cancer	0.000117	0.000886	CcSEcCtD
Topiramate—Asthenia—Cisplatin—esophageal cancer	0.000117	0.000884	CcSEcCtD
Topiramate—Cardiac disorder—Methotrexate—esophageal cancer	0.000116	0.000883	CcSEcCtD
Topiramate—Skin disorder—Capecitabine—esophageal cancer	0.000116	0.000882	CcSEcCtD
Topiramate—Hyperhidrosis—Capecitabine—esophageal cancer	0.000116	0.000878	CcSEcCtD
Topiramate—Anorexia—Capecitabine—esophageal cancer	0.000114	0.000866	CcSEcCtD
Topiramate—Angiopathy—Methotrexate—esophageal cancer	0.000114	0.000863	CcSEcCtD
Topiramate—Immune system disorder—Methotrexate—esophageal cancer	0.000113	0.00086	CcSEcCtD
Topiramate—Mediastinal disorder—Methotrexate—esophageal cancer	0.000113	0.000858	CcSEcCtD
Topiramate—Chills—Methotrexate—esophageal cancer	0.000113	0.000854	CcSEcCtD
Topiramate—Hypotension—Capecitabine—esophageal cancer	0.000112	0.000849	CcSEcCtD
Topiramate—Diarrhoea—Cisplatin—esophageal cancer	0.000111	0.000843	CcSEcCtD
Topiramate—Alopecia—Methotrexate—esophageal cancer	0.000111	0.000841	CcSEcCtD
Topiramate—Mental disorder—Methotrexate—esophageal cancer	0.00011	0.000834	CcSEcCtD
Topiramate—Erythema—Methotrexate—esophageal cancer	0.000109	0.000828	CcSEcCtD
Topiramate—Malnutrition—Methotrexate—esophageal cancer	0.000109	0.000828	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000109	0.000827	CcSEcCtD
Topiramate—Insomnia—Capecitabine—esophageal cancer	0.000108	0.000821	CcSEcCtD
Topiramate—Paraesthesia—Capecitabine—esophageal cancer	0.000108	0.000815	CcSEcCtD
Topiramate—Dysgeusia—Methotrexate—esophageal cancer	0.000107	0.000811	CcSEcCtD
Topiramate—Dyspnoea—Capecitabine—esophageal cancer	0.000107	0.00081	CcSEcCtD
Topiramate—Back pain—Methotrexate—esophageal cancer	0.000106	0.000801	CcSEcCtD
Topiramate—Dyspepsia—Capecitabine—esophageal cancer	0.000105	0.000799	CcSEcCtD
Topiramate—Decreased appetite—Capecitabine—esophageal cancer	0.000104	0.000789	CcSEcCtD
Topiramate—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000103	0.000784	CcSEcCtD
Topiramate—Vomiting—Cisplatin—esophageal cancer	0.000103	0.000783	CcSEcCtD
Topiramate—Fatigue—Capecitabine—esophageal cancer	0.000103	0.000783	CcSEcCtD
Topiramate—Vision blurred—Methotrexate—esophageal cancer	0.000103	0.000781	CcSEcCtD
Topiramate—Rash—Cisplatin—esophageal cancer	0.000102	0.000777	CcSEcCtD
Topiramate—Constipation—Capecitabine—esophageal cancer	0.000102	0.000777	CcSEcCtD
Topiramate—Pain—Capecitabine—esophageal cancer	0.000102	0.000777	CcSEcCtD
Topiramate—Dermatitis—Cisplatin—esophageal cancer	0.000102	0.000776	CcSEcCtD
Topiramate—Ill-defined disorder—Methotrexate—esophageal cancer	0.000101	0.000769	CcSEcCtD
Topiramate—Anaemia—Methotrexate—esophageal cancer	0.000101	0.000766	CcSEcCtD
Topiramate—Feeling abnormal—Capecitabine—esophageal cancer	9.87e-05	0.000748	CcSEcCtD
Topiramate—Malaise—Methotrexate—esophageal cancer	9.85e-05	0.000747	CcSEcCtD
Topiramate—Vertigo—Methotrexate—esophageal cancer	9.82e-05	0.000744	CcSEcCtD
Topiramate—Gastrointestinal pain—Capecitabine—esophageal cancer	9.79e-05	0.000743	CcSEcCtD
Topiramate—Leukopenia—Methotrexate—esophageal cancer	9.78e-05	0.000742	CcSEcCtD
Topiramate—Nausea—Cisplatin—esophageal cancer	9.65e-05	0.000732	CcSEcCtD
Topiramate—Cough—Methotrexate—esophageal cancer	9.53e-05	0.000723	CcSEcCtD
Topiramate—Urticaria—Capecitabine—esophageal cancer	9.51e-05	0.000721	CcSEcCtD
Topiramate—Body temperature increased—Capecitabine—esophageal cancer	9.47e-05	0.000718	CcSEcCtD
Topiramate—Abdominal pain—Capecitabine—esophageal cancer	9.47e-05	0.000718	CcSEcCtD
Topiramate—Convulsion—Methotrexate—esophageal cancer	9.47e-05	0.000718	CcSEcCtD
Topiramate—Arthralgia—Methotrexate—esophageal cancer	9.3e-05	0.000705	CcSEcCtD
Topiramate—Chest pain—Methotrexate—esophageal cancer	9.3e-05	0.000705	CcSEcCtD
Topiramate—Myalgia—Methotrexate—esophageal cancer	9.3e-05	0.000705	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	9.24e-05	0.0007	CcSEcCtD
Topiramate—Discomfort—Methotrexate—esophageal cancer	9.19e-05	0.000697	CcSEcCtD
Topiramate—Confusional state—Methotrexate—esophageal cancer	8.99e-05	0.000682	CcSEcCtD
Topiramate—Infection—Methotrexate—esophageal cancer	8.86e-05	0.000672	CcSEcCtD
Topiramate—Hypersensitivity—Capecitabine—esophageal cancer	8.82e-05	0.000669	CcSEcCtD
Topiramate—Nervous system disorder—Methotrexate—esophageal cancer	8.74e-05	0.000663	CcSEcCtD
Topiramate—Thrombocytopenia—Methotrexate—esophageal cancer	8.73e-05	0.000662	CcSEcCtD
Topiramate—Skin disorder—Methotrexate—esophageal cancer	8.66e-05	0.000657	CcSEcCtD
Topiramate—Hyperhidrosis—Methotrexate—esophageal cancer	8.62e-05	0.000654	CcSEcCtD
Topiramate—Asthenia—Capecitabine—esophageal cancer	8.59e-05	0.000652	CcSEcCtD
Topiramate—Anorexia—Methotrexate—esophageal cancer	8.5e-05	0.000644	CcSEcCtD
Topiramate—Pruritus—Capecitabine—esophageal cancer	8.47e-05	0.000643	CcSEcCtD
Topiramate—Hypotension—Methotrexate—esophageal cancer	8.33e-05	0.000632	CcSEcCtD
Topiramate—Diarrhoea—Capecitabine—esophageal cancer	8.19e-05	0.000621	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Methotrexate—esophageal cancer	8.12e-05	0.000616	CcSEcCtD
Topiramate—Insomnia—Methotrexate—esophageal cancer	8.06e-05	0.000611	CcSEcCtD
Topiramate—Paraesthesia—Methotrexate—esophageal cancer	8.01e-05	0.000607	CcSEcCtD
Topiramate—Dyspnoea—Methotrexate—esophageal cancer	7.95e-05	0.000603	CcSEcCtD
Topiramate—Somnolence—Methotrexate—esophageal cancer	7.93e-05	0.000601	CcSEcCtD
Topiramate—Dizziness—Capecitabine—esophageal cancer	7.92e-05	0.000601	CcSEcCtD
Topiramate—Dyspepsia—Methotrexate—esophageal cancer	7.85e-05	0.000595	CcSEcCtD
Topiramate—Decreased appetite—Methotrexate—esophageal cancer	7.75e-05	0.000588	CcSEcCtD
Topiramate—Gastrointestinal disorder—Methotrexate—esophageal cancer	7.7e-05	0.000584	CcSEcCtD
Topiramate—Fatigue—Methotrexate—esophageal cancer	7.69e-05	0.000583	CcSEcCtD
Topiramate—Pain—Methotrexate—esophageal cancer	7.62e-05	0.000578	CcSEcCtD
Topiramate—Vomiting—Capecitabine—esophageal cancer	7.62e-05	0.000577	CcSEcCtD
Topiramate—Rash—Capecitabine—esophageal cancer	7.55e-05	0.000573	CcSEcCtD
Topiramate—Dermatitis—Capecitabine—esophageal cancer	7.54e-05	0.000572	CcSEcCtD
Topiramate—Headache—Capecitabine—esophageal cancer	7.5e-05	0.000569	CcSEcCtD
Topiramate—Feeling abnormal—Methotrexate—esophageal cancer	7.35e-05	0.000557	CcSEcCtD
Topiramate—Gastrointestinal pain—Methotrexate—esophageal cancer	7.29e-05	0.000553	CcSEcCtD
Topiramate—Nausea—Capecitabine—esophageal cancer	7.11e-05	0.000539	CcSEcCtD
Topiramate—Urticaria—Methotrexate—esophageal cancer	7.08e-05	0.000537	CcSEcCtD
Topiramate—Abdominal pain—Methotrexate—esophageal cancer	7.05e-05	0.000534	CcSEcCtD
Topiramate—Body temperature increased—Methotrexate—esophageal cancer	7.05e-05	0.000534	CcSEcCtD
Topiramate—Hypersensitivity—Methotrexate—esophageal cancer	6.57e-05	0.000498	CcSEcCtD
Topiramate—Asthenia—Methotrexate—esophageal cancer	6.4e-05	0.000485	CcSEcCtD
Topiramate—Pruritus—Methotrexate—esophageal cancer	6.31e-05	0.000478	CcSEcCtD
Topiramate—Diarrhoea—Methotrexate—esophageal cancer	6.1e-05	0.000463	CcSEcCtD
Topiramate—Dizziness—Methotrexate—esophageal cancer	5.9e-05	0.000447	CcSEcCtD
Topiramate—Vomiting—Methotrexate—esophageal cancer	5.67e-05	0.00043	CcSEcCtD
Topiramate—Rash—Methotrexate—esophageal cancer	5.62e-05	0.000426	CcSEcCtD
Topiramate—Dermatitis—Methotrexate—esophageal cancer	5.62e-05	0.000426	CcSEcCtD
Topiramate—Headache—Methotrexate—esophageal cancer	5.59e-05	0.000424	CcSEcCtD
Topiramate—Nausea—Methotrexate—esophageal cancer	5.3e-05	0.000402	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—NOTCH1—esophageal cancer	3.58e-05	0.000251	CbGpPWpGaD
Topiramate—CA6—Metabolism—CYP1B1—esophageal cancer	3.58e-05	0.000251	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CYP1B1—esophageal cancer	3.58e-05	0.000251	CbGpPWpGaD
Topiramate—CA9—Metabolism—TYMP—esophageal cancer	3.57e-05	0.00025	CbGpPWpGaD
Topiramate—CA2—Metabolism—GAPDH—esophageal cancer	3.54e-05	0.000248	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—ABL1—esophageal cancer	3.53e-05	0.000247	CbGpPWpGaD
Topiramate—CA1—Metabolism—ALDOB—esophageal cancer	3.52e-05	0.000247	CbGpPWpGaD
Topiramate—CA2—Metabolism—CRABP1—esophageal cancer	3.51e-05	0.000245	CbGpPWpGaD
Topiramate—CA4—Metabolism—GNG7—esophageal cancer	3.48e-05	0.000243	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	3.48e-05	0.000243	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP26A1—esophageal cancer	3.47e-05	0.000243	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	3.42e-05	0.000239	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—SMAD4—esophageal cancer	3.42e-05	0.000239	CbGpPWpGaD
Topiramate—CA1—Metabolism—GAPDH—esophageal cancer	3.39e-05	0.000237	CbGpPWpGaD
Topiramate—CA9—Metabolism—ALOX15—esophageal cancer	3.39e-05	0.000237	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	3.37e-05	0.000236	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CYP19A1—esophageal cancer	3.37e-05	0.000236	CbGpPWpGaD
Topiramate—CA6—Metabolism—CYP19A1—esophageal cancer	3.37e-05	0.000236	CbGpPWpGaD
Topiramate—CA1—Metabolism—CRABP1—esophageal cancer	3.36e-05	0.000235	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CYP1B1—esophageal cancer	3.34e-05	0.000234	CbGpPWpGaD
Topiramate—CA7—Metabolism—CYP1B1—esophageal cancer	3.34e-05	0.000234	CbGpPWpGaD
Topiramate—CA2—Metabolism—GNG7—esophageal cancer	3.33e-05	0.000233	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—GNG7—esophageal cancer	3.27e-05	0.000229	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—CYP1B1—esophageal cancer	3.27e-05	0.000229	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—CDKN1A—esophageal cancer	3.26e-05	0.000228	CbGpPWpGaD
Topiramate—CA4—Metabolism—ALDH2—esophageal cancer	3.26e-05	0.000228	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—CREBBP—esophageal cancer	3.25e-05	0.000227	CbGpPWpGaD
Topiramate—CA9—Metabolism—TPI1—esophageal cancer	3.23e-05	0.000226	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTO1—esophageal cancer	3.23e-05	0.000226	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—CYP1B1—esophageal cancer	3.22e-05	0.000226	CbGpPWpGaD
Topiramate—CA1—Metabolism—GNG7—esophageal cancer	3.2e-05	0.000224	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	3.18e-05	0.000223	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	3.15e-05	0.000221	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CYP19A1—esophageal cancer	3.14e-05	0.00022	CbGpPWpGaD
Topiramate—CA7—Metabolism—CYP19A1—esophageal cancer	3.14e-05	0.00022	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	3.14e-05	0.000219	CbGpPWpGaD
Topiramate—CA2—Metabolism—ALDH2—esophageal cancer	3.12e-05	0.000219	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—EP300—esophageal cancer	3.1e-05	0.000217	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSTT1—esophageal cancer	3.1e-05	0.000217	CbGpPWpGaD
Topiramate—CA12—Metabolism—CYP1B1—esophageal cancer	3.1e-05	0.000217	CbGpPWpGaD
Topiramate—CA9—Metabolism—ALDOB—esophageal cancer	3.1e-05	0.000217	CbGpPWpGaD
Topiramate—CA6—Metabolism—HMOX1—esophageal cancer	3.07e-05	0.000215	CbGpPWpGaD
Topiramate—CA5A—Metabolism—HMOX1—esophageal cancer	3.07e-05	0.000215	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—CYP19A1—esophageal cancer	3.07e-05	0.000215	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP2A6—esophageal cancer	3.06e-05	0.000214	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—CYP19A1—esophageal cancer	3.03e-05	0.000212	CbGpPWpGaD
Topiramate—CA1—Metabolism—ALDH2—esophageal cancer	3e-05	0.00021	CbGpPWpGaD
Topiramate—CA9—Metabolism—GAPDH—esophageal cancer	2.98e-05	0.000209	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSTT1—esophageal cancer	2.97e-05	0.000208	CbGpPWpGaD
Topiramate—CA9—Metabolism—CRABP1—esophageal cancer	2.95e-05	0.000207	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ABCB1—esophageal cancer	2.95e-05	0.000206	CbGpPWpGaD
Topiramate—CA6—Metabolism—ABCB1—esophageal cancer	2.95e-05	0.000206	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP2A6—esophageal cancer	2.94e-05	0.000206	CbGpPWpGaD
Topiramate—CA12—Metabolism—CYP19A1—esophageal cancer	2.91e-05	0.000204	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS1—esophageal cancer	2.9e-05	0.000203	CbGpPWpGaD
Topiramate—CA4—Metabolism—ENO1—esophageal cancer	2.9e-05	0.000203	CbGpPWpGaD
Topiramate—CA7—Metabolism—HMOX1—esophageal cancer	2.87e-05	0.000201	CbGpPWpGaD
Topiramate—CA5B—Metabolism—HMOX1—esophageal cancer	2.87e-05	0.000201	CbGpPWpGaD
Topiramate—CA4—Metabolism—PSME2—esophageal cancer	2.86e-05	0.0002	CbGpPWpGaD
Topiramate—CA4—Metabolism—PSME1—esophageal cancer	2.86e-05	0.0002	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTT1—esophageal cancer	2.85e-05	0.000199	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP2A6—esophageal cancer	2.82e-05	0.000197	CbGpPWpGaD
Topiramate—CA9—Metabolism—GNG7—esophageal cancer	2.81e-05	0.000197	CbGpPWpGaD
Topiramate—CA2—Metabolism—ENO1—esophageal cancer	2.78e-05	0.000195	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS1—esophageal cancer	2.78e-05	0.000195	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ABCB1—esophageal cancer	2.75e-05	0.000193	CbGpPWpGaD
Topiramate—CA7—Metabolism—ABCB1—esophageal cancer	2.75e-05	0.000193	CbGpPWpGaD
Topiramate—CA2—Metabolism—PSME2—esophageal cancer	2.74e-05	0.000192	CbGpPWpGaD
Topiramate—CA2—Metabolism—PSME1—esophageal cancer	2.74e-05	0.000192	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—ERBB2—esophageal cancer	2.72e-05	0.00019	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—ERBB2—esophageal cancer	2.68e-05	0.000188	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—KDR—esophageal cancer	2.67e-05	0.000187	CbGpPWpGaD
Topiramate—CA1—Metabolism—ENO1—esophageal cancer	2.67e-05	0.000187	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS1—esophageal cancer	2.67e-05	0.000187	CbGpPWpGaD
Topiramate—CA12—Metabolism—HMOX1—esophageal cancer	2.66e-05	0.000186	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—EGFR—esophageal cancer	2.64e-05	0.000185	CbGpPWpGaD
Topiramate—CA9—Metabolism—ALDH2—esophageal cancer	2.63e-05	0.000184	CbGpPWpGaD
Topiramate—CA1—Metabolism—PSME1—esophageal cancer	2.63e-05	0.000184	CbGpPWpGaD
Topiramate—CA1—Metabolism—PSME2—esophageal cancer	2.63e-05	0.000184	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MET—esophageal cancer	2.62e-05	0.000183	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	2.59e-05	0.000181	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—EP300—esophageal cancer	2.58e-05	0.00018	CbGpPWpGaD
Topiramate—CA12—Metabolism—ABCB1—esophageal cancer	2.55e-05	0.000178	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NOTCH1—esophageal cancer	2.52e-05	0.000176	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTT1—esophageal cancer	2.5e-05	0.000175	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.49e-05	0.000174	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP2A6—esophageal cancer	2.48e-05	0.000173	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP1B1—esophageal cancer	2.47e-05	0.000173	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	2.47e-05	0.000173	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	2.44e-05	0.000171	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.39e-05	0.000167	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP1B1—esophageal cancer	2.37e-05	0.000166	CbGpPWpGaD
Topiramate—CA9—Metabolism—ENO1—esophageal cancer	2.35e-05	0.000164	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS1—esophageal cancer	2.35e-05	0.000164	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP19A1—esophageal cancer	2.32e-05	0.000163	CbGpPWpGaD
Topiramate—CA9—Metabolism—PSME2—esophageal cancer	2.31e-05	0.000162	CbGpPWpGaD
Topiramate—CA9—Metabolism—PSME1—esophageal cancer	2.31e-05	0.000162	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	2.31e-05	0.000162	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CREBBP—esophageal cancer	2.28e-05	0.00016	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.28e-05	0.000159	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP1B1—esophageal cancer	2.27e-05	0.000159	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP19A1—esophageal cancer	2.23e-05	0.000156	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—TP53—esophageal cancer	2.22e-05	0.000156	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—EP300—esophageal cancer	2.21e-05	0.000155	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.19e-05	0.000153	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP19A1—esophageal cancer	2.13e-05	0.000149	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	2.13e-05	0.000149	CbGpPWpGaD
Topiramate—CA4—Metabolism—HMOX1—esophageal cancer	2.12e-05	0.000148	CbGpPWpGaD
Topiramate—CA4—Metabolism—ABCB1—esophageal cancer	2.03e-05	0.000142	CbGpPWpGaD
Topiramate—CA2—Metabolism—HMOX1—esophageal cancer	2.03e-05	0.000142	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP1B1—esophageal cancer	2e-05	0.00014	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.99e-05	0.000139	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CREBBP—esophageal cancer	1.97e-05	0.000138	CbGpPWpGaD
Topiramate—CA6—Metabolism—CREBBP—esophageal cancer	1.97e-05	0.000138	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	1.96e-05	0.000137	CbGpPWpGaD
Topiramate—CA2—Metabolism—ABCB1—esophageal cancer	1.95e-05	0.000136	CbGpPWpGaD
Topiramate—CA1—Metabolism—HMOX1—esophageal cancer	1.95e-05	0.000136	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	1.94e-05	0.000136	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—ERBB2—esophageal cancer	1.91e-05	0.000134	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	1.91e-05	0.000134	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—EGFR—esophageal cancer	1.89e-05	0.000132	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP19A1—esophageal cancer	1.88e-05	0.000131	CbGpPWpGaD
Topiramate—CA1—Metabolism—ABCB1—esophageal cancer	1.87e-05	0.000131	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—EGFR—esophageal cancer	1.86e-05	0.00013	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	1.86e-05	0.00013	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	1.85e-05	0.000129	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CREBBP—esophageal cancer	1.84e-05	0.000129	CbGpPWpGaD
Topiramate—CA7—Metabolism—CREBBP—esophageal cancer	1.84e-05	0.000129	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	1.82e-05	0.000127	CbGpPWpGaD
Topiramate—CA5A—Metabolism—NOS3—esophageal cancer	1.76e-05	0.000123	CbGpPWpGaD
Topiramate—CA6—Metabolism—NOS3—esophageal cancer	1.76e-05	0.000123	CbGpPWpGaD
Topiramate—CA9—Metabolism—HMOX1—esophageal cancer	1.71e-05	0.00012	CbGpPWpGaD
Topiramate—CA12—Metabolism—CREBBP—esophageal cancer	1.7e-05	0.000119	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC52A3—esophageal cancer	1.65e-05	0.000116	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—BLVRB—esophageal cancer	1.65e-05	0.000116	CbGpPWpGaD
Topiramate—CA7—Metabolism—NOS3—esophageal cancer	1.65e-05	0.000115	CbGpPWpGaD
Topiramate—CA5B—Metabolism—NOS3—esophageal cancer	1.65e-05	0.000115	CbGpPWpGaD
Topiramate—CA9—Metabolism—ABCB1—esophageal cancer	1.64e-05	0.000115	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTGS2—esophageal cancer	1.61e-05	0.000113	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTGS2—esophageal cancer	1.61e-05	0.000113	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.6e-05	0.000112	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EP300—esophageal cancer	1.55e-05	0.000109	CbGpPWpGaD
Topiramate—CA12—Metabolism—NOS3—esophageal cancer	1.53e-05	0.000107	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTGS2—esophageal cancer	1.51e-05	0.000105	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTGS2—esophageal cancer	1.51e-05	0.000105	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.48e-05	0.000103	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.46e-05	0.000102	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC10A2—esophageal cancer	1.4e-05	9.82e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CA1—esophageal cancer	1.4e-05	9.82e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTGS2—esophageal cancer	1.4e-05	9.77e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—CREBBP—esophageal cancer	1.36e-05	9.51e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—EP300—esophageal cancer	1.34e-05	9.39e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—EP300—esophageal cancer	1.34e-05	9.39e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EGFR—esophageal cancer	1.33e-05	9.28e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—CREBBP—esophageal cancer	1.3e-05	9.12e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CA2—esophageal cancer	1.28e-05	8.98e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.28e-05	8.94e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.25e-05	8.78e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—EP300—esophageal cancer	1.25e-05	8.77e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—EP300—esophageal cancer	1.25e-05	8.77e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—CREBBP—esophageal cancer	1.25e-05	8.74e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—NOS3—esophageal cancer	1.22e-05	8.52e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ADH7—esophageal cancer	1.19e-05	8.35e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLCE1—esophageal cancer	1.19e-05	8.35e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.18e-05	8.26e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—NOS3—esophageal cancer	1.17e-05	8.17e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—EP300—esophageal cancer	1.16e-05	8.12e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—NOS3—esophageal cancer	1.12e-05	7.83e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS2—esophageal cancer	1.11e-05	7.79e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—CREBBP—esophageal cancer	1.1e-05	7.69e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS2—esophageal cancer	1.07e-05	7.47e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ADH1B—esophageal cancer	1.05e-05	7.32e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS2—esophageal cancer	1.02e-05	7.16e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TYMP—esophageal cancer	1e-05	7e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CA—esophageal cancer	9.93e-06	6.95e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CA—esophageal cancer	9.93e-06	6.95e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—BLVRB—esophageal cancer	9.92e-06	6.95e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC52A3—esophageal cancer	9.92e-06	6.95e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—NOS3—esophageal cancer	9.83e-06	6.88e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP26A1—esophageal cancer	9.73e-06	6.81e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALOX15—esophageal cancer	9.48e-06	6.63e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CA—esophageal cancer	9.27e-06	6.49e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CA—esophageal cancer	9.27e-06	6.49e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—EP300—esophageal cancer	9.26e-06	6.48e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TPI1—esophageal cancer	9.04e-06	6.33e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTO1—esophageal cancer	9.04e-06	6.33e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS2—esophageal cancer	8.99e-06	6.3e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—EP300—esophageal cancer	8.87e-06	6.21e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALDOB—esophageal cancer	8.67e-06	6.07e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CA—esophageal cancer	8.59e-06	6.01e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—EP300—esophageal cancer	8.51e-06	5.96e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CA1—esophageal cancer	8.44e-06	5.91e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC10A2—esophageal cancer	8.44e-06	5.91e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GAPDH—esophageal cancer	8.34e-06	5.84e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CRABP1—esophageal cancer	8.27e-06	5.79e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GNG7—esophageal cancer	7.87e-06	5.51e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CA2—esophageal cancer	7.72e-06	5.4e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—EP300—esophageal cancer	7.48e-06	5.24e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALDH2—esophageal cancer	7.37e-06	5.16e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLCE1—esophageal cancer	7.17e-06	5.02e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ADH7—esophageal cancer	7.17e-06	5.02e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTT1—esophageal cancer	7.01e-06	4.91e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP2A6—esophageal cancer	6.93e-06	4.85e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	6.9e-06	4.83e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CA—esophageal cancer	6.85e-06	4.79e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS1—esophageal cancer	6.57e-06	4.6e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ENO1—esophageal cancer	6.57e-06	4.6e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CA—esophageal cancer	6.56e-06	4.6e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PSME2—esophageal cancer	6.47e-06	4.53e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PSME1—esophageal cancer	6.47e-06	4.53e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CA—esophageal cancer	6.29e-06	4.41e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ADH1B—esophageal cancer	6.29e-06	4.4e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TYMP—esophageal cancer	6.01e-06	4.21e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP26A1—esophageal cancer	5.85e-06	4.09e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALOX15—esophageal cancer	5.7e-06	3.99e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.65e-06	3.96e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP1B1—esophageal cancer	5.59e-06	3.91e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CA—esophageal cancer	5.53e-06	3.87e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTO1—esophageal cancer	5.44e-06	3.81e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TPI1—esophageal cancer	5.44e-06	3.81e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP19A1—esophageal cancer	5.25e-06	3.68e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.21e-06	3.65e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.02e-06	3.51e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CRABP1—esophageal cancer	4.97e-06	3.48e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HMOX1—esophageal cancer	4.79e-06	3.35e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GNG7—esophageal cancer	4.73e-06	3.31e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.7e-06	3.29e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCB1—esophageal cancer	4.6e-06	3.22e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.43e-06	3.1e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.22e-06	2.95e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.17e-06	2.92e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS1—esophageal cancer	3.95e-06	2.77e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ENO1—esophageal cancer	3.95e-06	2.77e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PSME1—esophageal cancer	3.89e-06	2.72e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PSME2—esophageal cancer	3.89e-06	2.72e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.48e-06	2.43e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.36e-06	2.35e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.16e-06	2.21e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CREBBP—esophageal cancer	3.07e-06	2.15e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.88e-06	2.02e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.77e-06	1.94e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NOS3—esophageal cancer	2.75e-06	1.93e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS2—esophageal cancer	2.52e-06	1.76e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—EP300—esophageal cancer	2.09e-06	1.47e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.85e-06	1.29e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NOS3—esophageal cancer	1.66e-06	1.16e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.55e-06	1.08e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.51e-06	1.06e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—EP300—esophageal cancer	1.26e-06	8.81e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CA—esophageal cancer	9.31e-07	6.52e-06	CbGpPWpGaD
